Biopharmaceutical profile of cerivastatin, a novel HMG-CoA reductase inhibitor

被引：5
|
作者：
Muck, W
Ochmann, K
Mazzu, A
Lettieri, J
机构：
[1] BAYER AG,CLIN PHARMACOL,D-5600 WUPPERTAL,GERMANY
[2] BAYER CORP,CLIN PHARMACOL,W HAVEN,CT
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88701-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [21] Influence of age on the safety, tolerability, and pharmacokinetics of the novel HMG-CoA reductase inhibitor cerivastatin in healthy male volunteers
    Mazzu, A
    Lettieri, J
    Kaiser, L
    Mullican, W
    Heller, AH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (08): : 715 - 719
  • [22] Photostability of pitavastatin-A novel HMG-CoA reductase inhibitor
    Grobelny, Pawel
    Viola, Giampietro
    Vedaldi, Daniela
    Dall'Acqua, Francesco
    Gliszczynska-Swiglo, Anna
    Mielcarek, Jadwiga
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 50 (04) : 597 - 601
  • [23] Effects of HMG-CoA reductase inhibitor on hemostasis
    Koh, KK
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 76 (01) : 23 - 32
  • [24] Pitavastatin: The Newest HMG-CoA Reductase Inhibitor
    Watson, Karol E.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2010, 11 (01) : 28 - 34
  • [25] Pitavastatin: A New HMG-CoA Reductase Inhibitor
    Wensel, Terri M.
    Waldrop, Bruce A.
    Wensel, Brian
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 507 - 514
  • [26] Cerivastatin - A new HMG-CoA reductase inhibitor - In combination with the antacid Maalox(R): An investigation of the safety and pharmacokinetics
    Dietrich, H
    Ritter, W
    Wingender, W
    Unger, S
    Ochmann, K
    ATHEROSCLEROSIS, 1997, 130 : 101 - 101
  • [27] HMG-CoA reductase inhibitor cerivastatin prolonged rat cardiac allograft survival by blocking intercellular signals
    Horimoto, H
    Nakai, Y
    Nakahara, K
    Nomura, Y
    Mieno, S
    Sasaki, S
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (04): : 440 - 445
  • [28] HMG-CoA reductase inhibitor cerivastatin inhibits interleukin-6 expression and secretion in human adipocytes
    van Harmelen, V
    Skurk, T
    Röhrig, K
    Hauner, H
    HORMONE AND METABOLIC RESEARCH, 2003, 35 (08) : 466 - 470
  • [29] NK-104: a novel synthetic HMG-CoA reductase inhibitor
    Kajinami, K
    Mabuchi, H
    Saito, Y
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (11) : 2653 - 2661
  • [30] Phase I study to investigate the effects of cimetidine on the pharmacokinetics of cerivastatin - A new HMG-CoA reductase inhibitor
    Frey, R
    Ritter, W
    Unger, S
    Ochmann, K
    Wingender, W
    ATHEROSCLEROSIS, 1997, 130 : 103 - 103
12345